0MUC47Z
Supplement Upper Spine Bursa and Ligament to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | M Bursae and Ligaments |
| Operation | U Supplement |
| Body Part | C Upper Spine Bursa and Ligament |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a bursa or, much more commonly, a ligament that remains largely intact but needs additional structural support. A typical example is augmenting a partially torn ligament with a collagen patch, mesh, or allograft strip to bolster its strength without removing and fully replacing the native tissue.
This approach is chosen when a ligament has enough healthy tissue to preserve but is not strong enough on its own to withstand normal joint stress, often in cases of chronic laxity, partial tearing, or degenerative thinning. It is also used in some reconstructive techniques that combine native ligament preservation with graft augmentation, an increasingly common alternative to full replacement for certain knee and ankle ligament injuries. The added material integrates with the existing structure over time, aiming to restore joint stability while keeping as much of the patient's own tissue as possible.
Anatomy & Axis Detail
Upper Spine Bursa and Ligament
The upper spine bursa and ligament value covers the ligamentous structures of the cervical and upper thoracic spine, including the ligamentum flavum, interspinous ligaments, and posterior longitudinal ligament, which maintain segmental alignment and limit excessive motion between vertebrae. Supplement is performed when these ligaments have degenerated or become insufficient, a change that can contribute to spinal instability or contribute to stenosis, and the surgeon reinforces the existing ligament with graft or synthetic material rather than resecting and replacing it outright. This is distinct from spinal fusion procedures, which address the vertebral joints themselves rather than the ligamentous soft tissue. Because the upper spine has no laterality, documentation should instead specify the vertebral level and the ligament being reinforced.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders assign Supplement when the operative note describes reinforcing an existing bursa or ligament with graft, mesh, or other material while the native structure is left in place, not excised. Key language includes "augmented," "reinforced," or "buttressed with graft." The most frequent error is confusing this with Replacement - if the surgeon documents that the damaged ligament was removed before the new material was placed, Replacement is correct instead. Coders should also confirm the supplementing material is a recognized device or biologic value, since the device character of the procedure affects code selection.